Cargando…
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
OBJECTIVES: Patients with bile acid synthesis disorders (BASDs) due to single enzyme defects (SEDs) or Zellweger spectrum disorders (ZSDs) accumulate hepatotoxic atypical bile acids resulting in potentially fatal progressive liver disease. We evaluated the efficacy and safety of oral cholic acid in...
Autores principales: | Heubi, James E., Bove, Kevin E., Setchell, Kenneth D.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559188/ https://www.ncbi.nlm.nih.gov/pubmed/28644367 http://dx.doi.org/10.1097/MPG.0000000000001657 |
Ejemplares similares
-
Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2018) -
Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder
por: Heubi, James E., et al.
Publicado: (2018) -
Cholic acid therapy in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2016) -
Bile Acid Synthesis Disorder Masquerading as Intractable Vitamin D-Deficiency Rickets
por: Ahmad, Osman, et al.
Publicado: (2018) -
Cholbam® and Zellweger spectrum disorders: treatment implementation and management
por: Anderson, Janaina Nogueira, et al.
Publicado: (2021)